PT  - JOURNAL ARTICLE
AU  - Hoyle, Brian
ED  - Lexis, Chris P. H.
TI  - Metformin Doses Not Reduce Heart Failure after STEMI in Patients without Diabetes (GIPS-III)
DP  - 2014 Jun 01
TA  - MD Conference Express
PG  - 24--25
VI  - 14
IP  - 4
4099  - http://mdc.sagepub.com/content/14/4/24.short
4100  - http://mdc.sagepub.com/content/14/4/24.full
AB  - Results of a double-blind, randomized, placebo-controlled, parallel-group trial do not support the routine use of metformin in nondiabetic patients after ST-segment elevation myocardial infarction (STEMI) for the purpose of preserving myocardial function. Findings of the Metformin to Reduce Heart Failure After Myocardial Infarction trial [GIPS-III; Lexis CPH et al. JAMA 2014] are discussed in this article.